Which Treatment Offers Better Long-term Safety?
Understanding Wegovy Long-term Side Effects vs Mounjaro's Profile
Wegovy long-term side effects primarily stem from its GLP-1 receptor mechanism, with gastrointestinal effects typically diminishing after the initial dose escalation period. Clinical data from the STEP trials spanning 68 weeks reveal that nausea, vomiting, and diarrhoea become less frequent as patients adapt to maintenance dosing. Mounjaro's dual GIP/GLP-1 approach may cause similar digestive effects, though some patients report different tolerance patterns due to the additional receptor pathway activation.
Long-term cardiovascular data favours Wegovy, with the SELECT trial demonstrating a 20% reduction in major cardiovascular events over 33 months. Mounjaro's long-term cardiovascular outcomes remain under investigation through the SURPASS-CVOT trial, expected to complete in 2025. Both medications require careful monitoring for potential thyroid effects, though clinical significance remains minimal in human studies conducted to date.
Wegovy vs Mounjaro Pricing and Long-term Value
EverydayMeds offers transparent pricing for both treatments, with Wegovy starting at £79.99 for the 0.25mg starter dose using code FIRST40. Maintenance therapy at 2.4mg costs £209.99 per pen, whilst our Ultimate Stability Trio provides three months of 2.4mg supply for £649.99. Returning customers benefit from code DOSE25 applied at checkout for continued savings throughout their treatment journey.
Mounjaro pricing follows a different structure due to higher maintenance doses up to 15mg weekly. The total monthly cost comparison depends on your prescribed maintenance dose, with both treatments representing significant long-term investments. Our 2-pen and 3-pen bundles provide convenience for consistent supply without the need for frequent reordering during critical dose escalation phases.
Clinical Evidence for Wegovy Long-term Side Effects
The STEP 1 trial followed patients for 68 weeks, revealing that most Wegovy long-term side effects plateau after the dose escalation period. Wilding et al., NEJM, 2021, reported that gastrointestinal adverse events occurred in approximately 74% of patients but typically decreased in severity over time. Discontinuation rates due to adverse events remained around 7% in clinical trials.
STEP 5 extended follow-up to 104 weeks, confirming that serious adverse events remained consistent with the known safety profile. Gallbladder-related events occurred in 1.6% of Wegovy patients versus 0.7% with placebo, highlighting the importance of long-term monitoring by qualified healthcare providers.
How Wegovy Works: Mechanism Behind Long-term Effects
Wegovy functions as a GLP-1 receptor agonist, mimicking the natural incretin hormone that regulates blood glucose and gastric emptying. This mechanism explains why Wegovy long-term side effects predominantly affect the digestive system, particularly during initial treatment phases. The medication slows gastric emptying, leading to prolonged feelings of fullness but potentially causing nausea or delayed digestion. GLP-1 receptors in the brain's appetite centres contribute to reduced food cravings and portion control. Understanding this mechanism helps predict and manage long-term effects throughout treatment duration.
EverydayMeds Ordering Process for Both Treatments
Our streamlined process begins with a 3-minute online clinical assessment covering your medical history, current medications, and weight management goals. A qualified prescriber reviews your application within 3 working days (24 hours with express service), determining whether Wegovy or Mounjaro suits your long-term treatment needs. Both treatments require careful consideration of contraindications and potential drug interactions before prescribing. Once approved, next-day delivery ensures you receive your medication via temperature-controlled courier services. Our GPhC-registered pharmacy (#9012878) maintains strict cold-chain protocols throughout the supply process.
Storage Advantages: Wegovy vs Mounjaro Long-term Practicality
Wegovy offers superior storage flexibility, remaining stable at room temperature for up to 6 weeks once removed from refrigeration. This advantage proves valuable for travel or lifestyle flexibility during long-term treatment. Mounjaro requires refrigeration throughout its 21-day room temperature limit, potentially creating practical challenges for extended trips. Both medications utilise pre-filled FlexTouch pen systems for convenient weekly injections. The dose escalation schedule spans 16 weeks for Wegovy (reaching 2.4mg maintenance) versus Mounjaro's potential 20-week titration to maximum 15mg dosing. Proper storage maintains medication efficacy and reduces the risk of injection site reactions over extended treatment periods.
Comparative Long-term Safety Monitoring Requirements
Wegovy long-term side effects require specific monitoring protocols, including regular assessment of gastrointestinal symptoms, weight loss progression, and cardiovascular risk factors. Both medications carry MHRA additional monitoring status (Black Triangle ▼), necessitating careful adverse event reporting throughout treatment duration. Thyroid function monitoring remains important for both treatments, though clinical significance appears minimal based on current evidence.
Blood glucose monitoring becomes particularly relevant for patients with pre-diabetes or metabolic syndrome, as both medications may affect glucose homeostasis over extended periods. Regular prescriber consultations ensure that any emerging long-term effects receive prompt medical attention and appropriate treatment modifications when necessary.
Making Your Long-term Treatment Decision
Choosing between Wegovy and Mounjaro for long-term weight management requires careful consideration of individual health profiles, lifestyle factors, and tolerance patterns. EverydayMeds provides both options with comprehensive prescriber support to guide your decision-making process. New customers can start with either treatment using code FIRST40, whilst returning customers benefit from DOSE25 for ongoing savings. Both medications remain available through our secure online platform at https://everydaymeds.co.uk/collections/weight-loss with next-day delivery and continuous clinical support. Your prescriber will determine the most appropriate long-term option based on your specific medical needs and treatment objectives.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
